ASB6 and cancer: The differential expression analysis of ASB6 in pan-cancer also revealed significant upregulation in 12 cancer types (12/22, with 11 other types having too few or no normal samples), including the aforementioned cancers LIHC, LUSC, COAD, and READ (Figure 2B).